Real-world experience of CPX-351 as first-line treatment for patients with acute myeloid leukemiaChristina Rautenberg, Jan Moritz Middeke, Friedrich Stölzel et al.|Blood Cancer Journal|2021Cited by 65
Identification of critical hemodilution by artificial intelligence in bone marrow assessed for minimal residual disease analysis in acute myeloid leukemia: The Cinderella methodJoerg Hoffmann, Cornelia Brendel, Michael C. Thrun et al.|Cytometry Part A|2022Cited by 17
An Explainable AI System for the Diagnosis of High-Dimensional Biomedical DataAlfred Ultsch, Michael C. Thrun, Jörg Hoffmann et al.|BioMedInformatics|2024Cited by 10
Flow cytometry datasets consisting of peripheral blood and bone marrow samples for the evaluation of explainable artificial intelligence methodsMichael C. Thrun, Alfred Ultsch, Jörg Hoffmann et al.|Data in Brief|2022Cited by 10
Clonal architecture of del(5q) myelodysplastic syndromes: aberrant CD5 or CD7 expression within the myeloid progenitor compartment defines a subset with high clonal burdenUta Oelschlaegel, Uwe Platzbecker, Maximilian Alexander Röhnert et al.|Leukemia|2015Cited by 9